Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein–immunoglobulin G-associated Disease - 26/06/24
, Paolo Preziosa, MD, PhD a, b, e, Monica Margoni, MD, PhD a, b, c, Maria A. Rocca, MD a, b, eRésumé |
The diagnostic workup of multiple sclerosis (MS) has evolved considerably. The 2017 revision of the McDonald criteria shows high sensitivity and accuracy in predicting clinically definite MS in patients with a typical clinically isolated syndrome and allows an earlier MS diagnosis. Neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein–immunoglobulin G-associated disease (MOGAD) are recognized as separate conditions from MS, with specific diagnostic criteria. New MR imaging markers may improve diagnostic specificity for these conditions, thus reducing the risk of misdiagnosis. This study summarizes the most recent updates regarding the application of MR imaging for the diagnosis of MS, NMOSD, and MOGAD.
Le texte complet de cet article est disponible en PDF.Keywords : Multiple sclerosis, NMOSD, MOGAD, MR imaging, Differential diagnosis, Diagnostic criteria
Plan
Vol 34 - N° 3
P. 293-316 - août 2024 Retour au numéro
Article précédent
- Recent Advances in Neuroimaging of Multiple Sclerosis and Related Demyelinating Disorders
- Frederik Barkhof, Yaou Liu
- Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases
- Anthony Traboulsee, David K.B. Li
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?